University of Pennsylvania Amends Carisma Therapeutics Stake
Ticker: CARM · Form: SC 13D/A · Filed: Jan 26, 2024 · CIK: 1485003
Complexity: simple
Sentiment: neutral
Topics: insider-ownership, amendment, institutional-investor
TL;DR
**University of Pennsylvania just updated its Carisma Therapeutics ownership, watch for details!**
AI Summary
The Trustees of the University of Pennsylvania filed an amended SC 13D/A on January 26, 2024, regarding their ownership in Carisma Therapeutics Inc. This amendment, triggered by an event on September 15, 2023, indicates a change in their beneficial ownership of Carisma's Common Stock, par value $0.001. While the specific nature of the change isn't detailed in the provided text, it signals that a significant institutional holder has updated its position, which could influence investor perception and stock stability for current and prospective shareholders.
Why It Matters
This filing shows that a major institutional investor, the University of Pennsylvania, has updated its stake in Carisma Therapeutics, which can signal changes in their investment strategy or confidence in the company's future.
Risk Assessment
Risk Level: medium — The filing indicates a change in a significant holder's position, but without specific details on the change (increase or decrease), it introduces uncertainty for investors.
Analyst Insight
Investors should monitor subsequent filings or company announcements to understand the specific nature of the change in the University of Pennsylvania's beneficial ownership, as this could indicate a bullish or bearish signal depending on whether they increased or decreased their stake.
Key Numbers
- $0.001 — Par Value per Share (The par value of Carisma Therapeutics Inc. Common Stock.)
- 14216R 101 — CUSIP Number (The CUSIP number for Carisma Therapeutics Inc. Common Stock.)
Key Players & Entities
- Carisma Therapeutics Inc. (company) — the subject company of the filing
- Trustees of the University of Pennsylvania (company) — the reporting person filing the SC 13D/A
- $0.001 (dollar_amount) — par value of Carisma Therapeutics Common Stock
- September 15, 2023 (date) — date of the event requiring the filing
- January 26, 2024 (date) — date the SC 13D/A was filed
Forward-Looking Statements
- The University of Pennsylvania's updated stake could signal a shift in their long-term investment strategy for Carisma Therapeutics. (Trustees of the University of Pennsylvania) — medium confidence, target: 2024-12-31
FAQ
Who filed this SC 13D/A amendment?
The Trustees of the University of Pennsylvania filed this SC 13D/A amendment.
What is the subject company of this filing?
The subject company is Carisma Therapeutics Inc., with CIK 0001485003.
What was the date of the event that required this filing?
The event that required this filing occurred on September 15, 2023.
What is the par value of Carisma Therapeutics Inc.'s Common Stock?
The par value of Carisma Therapeutics Inc.'s Common Stock is $0.001.
What is the business address of the Trustees of the University of Pennsylvania as listed in the filing?
Their business address is 3451 Walnut Street, Suite 714, Philadelphia, PA 19104.
Filing Stats: 779 words · 3 min read · ~3 pages · Grade level 8.8 · Accepted 2024-01-26 16:31:00
Key Financial Figures
- $0.001 — me of Issuer) Common Stock, par value $0.001 (Title of Class of Securities) 1421
Filing Documents
- d182966dsc13da.htm (SC 13D/A) — 37KB
- 0001193125-24-016760.txt ( ) — 39KB
Interest in Securities of the Issuer
Item 5. Interest in Securities of the Issuer. The disclosures provided in Item 5(a) (c) of the Original Schedule 13D are hereby amended and restated in their entirety as follows: (a) and (b) Items 7 to 11 of the cover pages of this Schedule 13D are incorporated herein by reference. (c) The transactions effected by the Reporting Person in respect of Common Stock since the most recent filing of the Reporting Person on Schedule 13D are set forth on the below table. All transactions below were effected by the Reporting Person in open market transactions at prevailing markets prices. Transaction Date Price Per Share Number of Shares Transaction 9/13/2023 5.0000 2,762 Sale 9/13/2023 4.8242 19,884 Sale 9/14/2023 4.7232 23,043 Sale 9/15/2023 4.8628 43,683 Sale 9/15/2023 5.0133 600 Sale 9/18/2023 5.0000 200 Sale 9/18/2023 4.8095 29,462 Sale 9/19/2023 4.6000 35,380 Sale 9/20/2023 4.5610 32,801 Sale 9/21/2023 3.9681 61,003 Sale 9/22/2023 3.9459 38,669 Sale 9/22/2023 4.0700 80 Sale 9/25/2023 4.0992 23,908 Sale 9/26/2023 4.2474 13,741 Sale 9/27/2023 4.4373 41,186 Sale 9/28/2023 4.3725 27,254 Sale 9/29/2023 4.2700 29,312 Sale 10/2/2023 4.2569 11,299 Sale 10/9/2023 4.3295 16,382 Sale 10/10/2023 4.3141 22,530 Sale 10/11/2023 4.1729 82,680 Sale 10/12/2023 3.5780 57,745 Sale 10/13/2023 3.4588 57,547 Sale 10/16/2023 3.3783 38,638 Sale 10/17/2023 3.3855 42,968 Sale 10/18/2023 3.0518 42,889 Sale 10/19/2023 2.9741 28,615 Sale 10/20/2023 2.8496 25,963 Sale 10/23/2023 2.7788 40,794 Sale 10/24/2023 2.8627 27,662 Sale 10/25/2023 2.7829 12,025 Sale SIGNATURE After reasonable inquiry and to the best of the undersigneds knowledge and belief, the undersigned hereby certifies that the information set forth in this statement is true, co